ArrowMark Colorado Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

ArrowMark Colorado Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10M	Sell	18,624 -43,817	-70%	-$22.4M	0.42%	90
2026 Q1	$32.7M	Sell	62,441 -20,183	-24%	-$9.64M	0.87%	36
2025 Q4	$48.1M	Sell	82,624 -40,635	-33%	-$20.8M	1.06%	28
2025 Q3	$56.5M	Sell	123,259 -21,549	-15%	-$8.04M	1.05%	32
2025 Q2	$43.8M	Sell	144,808 -35,301	-20%	-$10.5M	0.79%	43
2025 Q1	$59.7M	Sell	180,109 -19,558	-10%	-$6.43M	0.97%	35
2024 Q4	$61.6M	Buy	199,667 +37,715	+23%	+$10.6M	0.83%	39
2024 Q3	$34.4M	Sell	161,952 -25,441	-14%	-$6.51M	0.44%	67
2024 Q2	$52.5M	Buy	187,393 +153,174	+448%	+$36.5M	0.63%	46
2024 Q1	$9.14M	Buy	+34,219	New	+$8.06M	0.1%	156

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ArrowMark Colorado Holdings's MDGL Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its Madrigal Pharmaceuticals (MDGL) stake by 70% in Q2 2026, selling an estimated $22.4M and leaving 18,624 shares worth $10M. The position accounts for 0.42% of the portfolio, ranked #90.

ArrowMark Colorado Holdings first reported a position in MDGL in Q1 2024 and has held it in 10 quarters since. The position peaked at $61.6M in Q4 2024. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

ArrowMark Colorado Holdings held 18,624 shares of Madrigal Pharmaceuticals worth $10M as of Q2 2026.
ArrowMark Colorado Holdings sold 43,817 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $22.4M.
Madrigal Pharmaceuticals made up 0.42% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #90 holding.
ArrowMark Colorado Holdings first reported a position in Madrigal Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
ArrowMark Colorado Holdings's Madrigal Pharmaceuticals position peaked at $61.6M in Q4 2024.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.